Clinical Scorecard: Digital CBT Outperforms Psychoeducation in Generalized Anxiety Disorder
At a Glance
| Category | Detail |
|---|---|
| Condition | Generalized Anxiety Disorder (GAD) |
| Key Mechanisms | Smartphone-delivered digital cognitive behavioral therapy (DCBT) |
| Target Population | Adults with interview-confirmed GAD and severe baseline symptoms (GAD-7 score of 15 or higher) |
| Care Setting | Remote, self-directed intervention |
Key Highlights
- DCBT showed significantly greater improvements in remission rates compared to psychoeducation.
- 71.0% of DCBT participants achieved remission at 10 weeks, increasing to 77.7% at 24 weeks.
- Self-reported anxiety symptoms were significantly lower in the DCBT group at all postbaseline time points.
- Secondary outcomes showed improvements in depressive symptoms and sleep quality.
- Adverse events were infrequent and similar between both treatment groups.
Guideline-Based Recommendations
Diagnosis
- Use the GAD-7 scale for screening and assessing severity of GAD.
Management
- Consider DCBT as a first-line treatment option for GAD, especially in settings with limited access to traditional therapy.
Monitoring & Follow-up
- Assess symptom improvement at regular intervals, particularly at 10 and 24 weeks.
Risks
- Monitor for adverse events, although they were infrequent in the trial.
Patient & Prescribing Data
Adults with severe GAD symptoms
Engagement with the DCBT program correlates with greater symptom improvement.
Clinical Best Practices
- Incorporate DCBT into stepped-care or adjunctive care models.
- Encourage completion of lessons and techniques for better outcomes.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.